Status, quality and specific needs of Zika virus (ZIKV) diagnostic capacity and capability in National Reference Laboratories for arboviruses in 30 EU/EEA countries, MAY 2016

Eurosurveillance

Volumn 22, Issue 36, 2017, Pages

  Mogling R ^a   Zeller, H ^b   Revez, J ^b   Koopmans, M ^a,c   Reusken, Chantal ^a   Aberle, Stephan ^d   Van Esbroeck, Marjan ^e   Christova, Iva ^f   Vilibic Cavlek, Tatjana ^g   Richter, Jan ^h   Zelena, Hana ⁱ   Fomsgaard, Anders ^j   Jaaskelainen, Anne J ^k,l   Brichler, Segolene ^m   Illiaquer, Marina ⁿ   Gonfrier, Geraldine ^o   Leparc Goffart, Isabelle ^p   Poveda, Jean Dominique ^q   Hober, D ^r   Fleury, H ^s   Fafi Kremer, Samira ^t   Foulongne, V ^u   Henquell, Cecile ^v   Leveque, Nicolas ^w   Carles, Marie Josee ^x   Mansuy, J M ^y   Schmidt Chanasit, Jonas ^z   Nitsche, Andreas ^aa   Papa, Anna ^ab   Mentis, Andreas ^ac   Takacs, Maria ^ad   Love, Arthur ^ae   Connell, Jeff ^af   Venturi, Giulietta ^ag   Storoženko, Jelena ^ah   Griskevicius, Algirdas ^ai   Opp, Matthias ^aj   Barbara, Christopher ^ak   Reimerink, Johan ^al   Dudman, Susanne Gjeruldsen ^am   Pancer, Katarzyna ^an   Alves, Maria Joao ^ao   Ceianu, Cornelia S ^ap   Ticha, Elena ^aq   Županc, Tatjana Avšič ^ar   Sanchez Seco, Maria Paz ^as   Tolfvenstam, Thomas ^at   Aarons, Emma ^au   more..

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^c Laboratory for Zoonoses and Environmental Microbiology   (Netherlands)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

^e INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^f NATIONAL CENTER OF INFECTIOUS AND PARASITIC DISEASES   (Bulgaria)

^g CROATIAN NATIONAL INSTITUTE OF PUBLIC HEALTH   (Croatia)

^h CYPRUS INSTITUTE OF NEUROLOGY AND GENETICS   (Cyprus)

ⁱ NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

^j STATENS SERUM INSTITUT   (Denmark)

^k Health Board   (Estonia)

^l HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^m SERVICE D ENDOCRINOLOGIE   (France)

ⁿ NANTES UNIVERSITY HOSPITAL   (France)

^o UNIVERSITY HOSPITAL OF NICE   (France)

^p INSTITUT DE RECHERCHE BIOMÉDICALE DES ARMÉES   (France)

^q LABORATOIRE CERBA   (France)

^r LILLE UNIVERSITY HOSPITAL   (France)

^s BORDEAUX UNIVERSITY HOSPITAL   (France)

^t UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^u MONTPELLIER UNIVERSITY HOSPITAL   (France)

^v UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^w POITIERS UNIVERSITY HOSPITAL   (France)

^x NÎMES UNIVERSITY HOSPITAL   (France)

^y TOULOUSE UNIVERSITY HOSPITAL   (France)

^z BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^aa ROBERT KOCH INSTITUTE   (Germany)

^ab ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^ac HELLENIC PASTEUR INSTITUTE   (Greece)

^ad NATIONAL CENTER FOR EPIDEMIOLOGY   (Hungary)

^ae LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^af UNIVERSITY COLLEGE DUBLIN   (Ireland)

^ag ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^ah RIGA EAST UNIVERSITY HOSPITAL   (Latvia)

^ai National Public Health Surveillance Laboratory   (Lithuania)

^aj LABORATOIRE NATIONAL DE SANTÉ   (Luxembourg)

^ak MATER DEI HOSPITAL   (Malta)

^al NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^am NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^an NATIONAL MEDICINES INSTITUTE   (Poland)

^ao NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

^ap Ion Cantacuzino National Institute of Microbiology   (Romania)

^aq Public Health Authority of the Slovak Republic   (Slovakia)

^ar UNIVERSITY OF LJUBLJANA   (Slovenia)

^as INSTITUTO DE SALUD CARLOS III   (Spain)

^at SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^au PUBLIC HEALTH ENGLAND   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARBOVIRUS; DIAGNOSTIC TEST ACCURACY STUDY; EUROPE; EUROPEAN UNION; HUMAN; HUMAN EXPERIMENT; NONHUMAN; PRACTICE GUIDELINE; QUESTIONNAIRE; TRAVEL; ZIKA VIRUS; COMMUNICABLE DISEASE; EPIDEMIC; HEALTH CARE QUALITY; HEALTH SURVEY; ISOLATION AND PURIFICATION; LABORATORY; PROCEDURES; STANDARDS; ZIKA FEVER;

COMMUNICABLE DISEASES, EMERGING; DISEASE OUTBREAKS; EUROPE; HUMANS; LABORATORIES; POPULATION SURVEILLANCE; QUALITY ASSURANCE, HEALTH CARE; ZIKA VIRUS; ZIKA VIRUS INFECTION;

EID: 85029858093     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES.2017.22.36.30609     Document Type: Article

References (37)

1. Hayes EB. Zika virus outside Africa. Emerg Infect Dis. 2009;15(9):1347-50. DOI: 10.3201/eid1509.090442 PMID: 19788800
2. Krauer F, Riesen M, Reveiz L, Oladapo OT, Martinez-Vega R, Porgo TV, et al. Zika Virus Infection as a Cause of Congenital Brain Abnormalities and Guillain-Barre Syndrome: Systematic Review. PLoS Med. 2017;14(1):e1002203. DOI: 10.1371/journal. pmed.1002203 PMID: 28045901
3. World Health Organization (WHO). WHO statement on the first meeting of the International Health Regulations (2005) (IHR 2005) Emergency Committee on Zika virus and observed increase in neurological disorders and neonatal malformations. Geneva: WHO; 2016. Available from: http://www.who.int/mediacentre/news/ statements/2016/1st-emergency-committee-zika/en/
4. Pan American Health Organization (PAHO). 2016: The year Zika evolved from an emergency into a long-term public health challenge. Washington: PAHO; 2016. Available from: http:// www.paho.org/hq/index.php?option=com_content&view=artic le&id=12861&Itemid=1926&lang=en
5. World Health Organization (WHO). Fifth meeting of the Emergency Commitee under the International Health Regulations (2005) regarding microcephaly, other neurological disorders and Zika virus. Geneva: WHO; 2016. Available from: http://www.who.int/mediacentre/news/statements/2016/ zika-fifth-ec/en/
6. Charrel RN, Leparc-Goffart I, Pas S, de Lamballerie X, Koopmans M, Reusken C. Background review for diagnostic test development for Zika virus infection.Bull World Health Organ. 2016;94(8):574-584D. DOI: 10.2471/BLT.16.171207 PMID: 27516635
7. Musso D, Roche C, Nhan TX, Robin E, Teissier A, Cao-Lormeau VM. Detection of Zika virus in saliva. J Clin Virol. 2015;68:53-5. DOI: 10.1016/j.jcv.2015.04.021 PMID: 26071336
8. Gourinat AC, O’Connor O, Calvez E, Goarant C, Dupont-Rouzeyrol M. Detection of Zika virus in urine. Emerg Infect Dis. 2015;21(1):84-6. DOI: 10.3201/eid2101.140894 PMID: 25530324
9. Mansuy JM, Mengelle C, Pasquier C, Chapuy-Regaud S, Delobel P, Martin-Blondel G, et al. Zika Virus Infection and Prolonged Viremia in Whole-Blood Specimens. Emerg Infect Dis. 2017;23(5):863-5. DOI: 10.3201/eid2305.161631 PMID: 28257281
10. Baud D, Musso D, Vouga M, Alves MP, Vulliemoz N. Zika virus: A new threat to human reproduction. Am J Reprod Immunol. 2017;77(2).PMID: 27966802
11. Vouga M, Musso D, Van Mieghem T, Baud D. CDC guidelines for pregnant women during the Zika virus outbreak. Lancet. 2016;387(10021):843-4. DOI: 10.1016/S0140-6736(16)00383-4 PMID: 26898855
12. Hamer DH, Barbre KA, Chen LH, Grobusch MP, Schlagenhauf P, Goorhuis A, et al. Travel-Associated Zika Virus Disease Acquired in the Americas Through February 2016: A GeoSentinel Analysis. Ann Intern Med. 2017;166(2):99-108. PMID: 27893080
13. Rocklov J, Quam MB, Sudre B, German M, Kraemer MU, Brady O, et al. Assessing Seasonal Risks for the Introduction and Mosquito-borne Spread of Zika Virus in Europe. EBioMedicine. 2016;9:250-6. DOI: 10.1016/j.ebiom.2016.06.009 PMID: 27344225
14. European Centre for Disease Prevention and Control (ECDC). Rapid Risk Assessment. Zika virus disease epidemic, Tenth update, 4 April 2017. Stockholm: ECDC; 2017. Available from: https://ecdc.europa.eu/sites/portal/files/media/en/ publications/Publications/21-03-2017-RRA%20UPDATE%20 9-Zika%20virus-Americas%2C%20Caribbean%2C%20 Oceania%2C%20Asia.pdf
15. European Centre for Disease Prevention and Control (ECDC). Rapid risk assessment. Zika virus disease epidemic. Ninth update, 28 October 2016. Stockholm: ECDC; 2016. Available from: http://ecdc.europa.eu/en/publications/Publications/ rapid-risk-assessment-zika-october-2016.pdf
16. World Health Organization Regional Office for Europe (WHO Europe). Zika virus. Technical report. Copenhagen: WHO Europe 2016. Available from: http://www.euro.who.int/__data/ assets/pdf_file/0003/309981/Zika-Virus-Technical-report.pdf
17. European Centre for Disease Prevention and Control (ECDC). Aedes albopictus-current known distribution in Europe, April 2017. Stockholm: ECDC; 2017. Available from: https://ecdc.europa.eu/en/publications-data/ aedes-albopictus-current-known-distribution-europe-april-2017
18. European Centre for Disease Prevention and Control (ECDC). Coordinating Competent Bodies: structures, interactions and terms of reference. Stockholm: ECDC; 2012. Available from: http://ecdc.europa.eu/en/aboutus/governance/competentbodies/ Documents/coordinating-competent-bodies-structuresterms-of-reference-and-interactions-w-Annexes.pdf
19. European Union. Directive 2000/54/EC of the European Parliament and of the Council of 18 September 2000 on the protection of workers from risks related to exposure to biological agents at work (seventh individual directive within the meaning of Article 16(1) of Directive 89/391/EEC). Official Journal of the European Communities. 2000. L 262/21. Available from: http://eur-lex.europa.eu/legal-content/EN/TXT/ PDF/?uri=CELEX:32000L0054&from=EN
20. Pathogens. ACoD. The Approved List of biological agents. 3rd edition. Bootle: Health and Safety Executive; 2013. Available from: http://www.hse.gov.uk/pubns/misc208.pdf
21. European Centre for Disease Prevention and Control (ECDC). Rapid risk assessment: Zika virus disease epidemic: potential association with microcephaly and Guillain-Barre syndrome. Fifth update, 12 April 2016. Stockholm: ECDC; 2016. Available from: http://ecdc.europa.eu/en/ publications/_layouts/forms/Publication_DispForm. aspx?List=4f55ad51-4aed-4d32-b960-af70113dbb90&ID=1466
22. de Sousa R, Reusken C, Koopmans M. MERS coronavirus: data gaps for laboratory preparedness. J Clin Virol. 2014;59(1):4-11. DOI: 10.1016/j.jcv.2013.10.030 PMID: 24286807
23. Cleton N, Koopmans M, Reimerink J, Godeke GJ, Reusken C. Come fly with me: review of clinically important arboviruses for global travelers. J Clin Virol. 2012;55(3):191-203. DOI: 10.1016/j. jcv.2012.07.004 PMID: 22840968
24. Cleton N, Reusken C, Murk JL, de Jong M, Reimerink J, van der Eijk A, et al. Using routine diagnostic data as a method of surveillance of arboviral infection in travellers: a comparative analysis with a focus on dengue. Travel Med Infect Dis. 2014;12(2):159-66. DOI: 10.1016/j.tmaid.2013.10.015 PMID: 24291263
25. Lanciotti RS, Kosoy OL, Laven JJ, Velez JO, Lambert AJ, Johnson AJ, et al. Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis. 2008;14(8):1232-9. DOI: 10.3201/ eid1408.080287 PMID: 18680646
26. Faye O, Faye O, Diallo D, Diallo M, Weidmann M, Sall AA. Quantitative real-time PCR detection of Zika virus and evaluation with field-caught mosquitoes.Virol J. 2013;10(1):311. DOI: 10.1186/1743-422X-10-311 PMID: 24148652
27. International Organization for Standardization (ISO). ISO 15189:2012(en). Geneva: ISO; 2012. Available from: https:// www.iso.org/obp/ui/#iso:std:iso:15189:ed-3:en
28. International Organization for Standardization (ISO). ISO/IEC 17025:2005. Geneva: ISO; 2005. Available from: https://www. iso.org/obp/ui/#iso:std:iso-iec:17025:ed-2:v1:en
29. International Organization for Standardization (ISO). ISO9001:2015(en). Geneva: ISO; 2015. Available from: https:// www.iso.org/obp/ui/#iso:std:62085:en
30. European Centre for Disease Prevention and Control (ECDC). ECDC Technical document. Zika virus disease epidemic: Interim guidance for healthcare providers and Zika virus laboratory diagnosis. Stockholm: ECDC; 2016. Available from: http://ecdc. europa.eu/en/publications/Publications/zika-virus-guidancehealthcare-providers-and-laboratory-diagnosis.pdf
31. Pan American Health Organization (PAHO). Zika virus (ZIKV) Surveillance in the Americas: laboratory detection and diagnosis. Algorithm for detecting Zika virus (ZIKV). Washington: PAHO; 2016. Available from: http://www.paho. org/hq/index.php?option=com_docman&task=doc_view&gid= 30176&Itemid=270&lang=en
32. World Health organization (WHO). Laboratory testing for Zika virus infection; Interim guidance 23 March 2016. Geneva: WHO; 2016. Available from: http://apps.who.int/iris/ bitstream/10665/204671/1/WHO_ZIKV_LAB_16.1_eng.pdf
33. World Health organization (WHO). Emergency Use Assessment and Listing (EUAL); Update on submission of applications to the WHO EUAL for Zika Virus IVDs. Geneva: WHO; 2016. Available from: http://www.who.int/diagnostics_laboratory/ eual-zika-virus/161201_zika_updates.pdf?ua=1
34. European Commission. European Union invests €45 million into research to combat the Zika disease. Brussels: EC; 2016. Available from: http://ec.europa.eu/research/index.cfm?pg=ne wsalert&year=2016&na=na-211016
35. Corman VM, Rasche A, Baronti C, Aldabbagh S, Cadar D, Reusken CB, et al. Assay optimization for molecular detection of Zika virus. Bull World Health Organ. 2016;94(12):880-92. DOI: 10.2471/BLT.16.175950 PMID: 27994281
36. European Centre for Disease Prevention and Control (ECDC). Emerging Viral Diseases-Expert Laboratory Network (EVD LabNet). ECDC. Stockholm: ECDC. [Accessed; August 2016]. Available from: https://ecdc.europa.eu/en/about-us/ partnerships-and-networks/disease-and-laboratory-networks/ evd-labnet
37. Charrel R, Mogling R, Pas S, Papa A, Baronti C, Koopmans M, et al. Variable sensitivity in molecular detection of Zika virus in European expert laboratories; external quality assessment, November 2016. J Clin Microbiol. Forthcoming.